ARCHIVES

NCI Director and Acting FDA Commissioner Andrew von Eschenbach Endorses Rep. E. Clay Shaw In Tour of Florida Congressman’s District. Von Eschenbach Praises Shaw’s “Leadership” In Seeking Funding For Research, Support of 2015 Goal.

This article is from The Cancer Letter archive.

Vol. 32 No. 04 | February 3, 2006

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Concepts For New CTEP, RRP Grants

February 24, 1989

Virus Program Changes reviews Subcommittee Report Set Fro June

November 23, 1974

NCI Leaders, Others Defend Cancer Program Against Bailar’s Charge They Are Losing War Against Cancer

May 16, 1986

Drug Shortages Prompt Doctors, Societies to Consider Non-Profit Pharma Company

September 9, 2011

New Policy on Minor Changes in Trials Requires Halt in Patient Enrollment.

April 25, 2008

Chemical Distribution To Grantees Delayed while HEW Considers Charging For It

June 22, 1979